Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Akkermansia muciniphila inactivated & Metabolic syndrome (MetS)

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Conclusions from randomized clinical trials (RCTs)

NCT05114018 - Akkermansia muciniphila MucT TM & Metabolic syndrome (MetS)

For this randomized clinical treatment trial, no published were found as of March 2026

NCT02637115 - Microbes4U - Akkermansia muciniphila vs Akkermansia muciniphila (killed) vs placebo & Metabolic Syndrome (MetS)

This randomized clinical basic science trial highlights the potential benefits of Akkermansia muciniphila inactivated in improving metabolic health markers, with significant effects on insulin sens…

References (Sources)

Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Depommier et al. 2019 Nat Med. 25(7): 1096-1103

AI Chat

5/29/2026

Chat with our artificial intelligence:

Start chat!